Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. HERBESSER TABLET 30 MG [SIN00428P]

HERBESSER TABLET 30 MG [SIN00428P]

Active ingredients: HERBESSER TABLET 30 MG

Last updated 26 October 2025

On this page

Product Info
INDICATIONS
DOSAGE AND ADMINISTRATION
CONTRAINDICATIONS (HERBESSER and HERBESSER 60 are contraindicated in the following patients.)

Product Info

HERBESSER TABLET 30 MG

[SIN00428P]

Product information

Active Ingredient and Strength

DILTIAZEM HCL - 30 MG

Dosage Form

TABLET

Manufacturer and Country

PT MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA REP OF

Registration Number

SIN00428P

Licence Holder

MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

C08DB01

INDICATIONS

  • Angina pectoris, variant angina pectoris

  • Essential hypertension (mild to moderate)

DOSAGE AND ADMINISTRATION

  • Angina pectoris, variant angina pectoris
    The usual adult dosage for oral use is 30 mg of diltiazem hydrochloride three times a day (90 mg/day). The dosage may be increased to 60 mg three times a day (180 mg/day), if necessary.

  • Essential hypertension (mild to moderate)
    The usual adult dosage for oral use is 30 to 60 mg of diltiazem hydrochloride three times a day (90 – 180 mg/day). The dosage may be adjusted depending on the patient’s age and symptoms.

CONTRAINDICATIONS (HERBESSER and HERBESSER 60 are contraindicated in the following patients.)

  1. Patients with severe congestive heart failure. [The symptoms of heart failure may be exacerbated.]

  2. Patients with 2nd- or 3rd-degree atrioventricular block or sick sinus syndrome (continuous sinus bradycardia (less than 50 beats/minute), sinus arrest, sinoatrial block, etc.) [Excessive inhibition of sinus rhythm and cardiac conduction may occur.]

  3. Patients with a history of hypersensitivity to any of the ingredients in the drug.

  4. Pregnant women or women who may possibly be pregnant, etc. [See PRECAUTIONS – Use during Pregnancy, Delivery or Lactation – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.]

  5. Patients receiving ivabradine hydrochloride. [See “Drug Interactions” section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.]